Daiwa Securities Group’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1K | Hold |
909
| – | – | ﹤0.01% | 1274 |
|
2025
Q1 | $1K | Hold |
909
| – | – | ﹤0.01% | 1241 |
|
2024
Q4 | $2K | Hold |
909
| – | – | ﹤0.01% | 1225 |
|
2024
Q3 | $2K | Sell |
909
-234,399
| -100% | -$516K | ﹤0.01% | 1224 |
|
2024
Q2 | $322K | Buy |
235,308
+9,516
| +4% | +$13K | ﹤0.01% | 902 |
|
2024
Q1 | $846K | Buy |
225,792
+224,883
| +24,740% | +$843K | ﹤0.01% | 742 |
|
2023
Q4 | $9K | Hold |
909
| – | – | ﹤0.01% | 1166 |
|
2023
Q3 | $8K | Hold |
909
| – | – | ﹤0.01% | 1131 |
|
2023
Q2 | $12K | Hold |
909
| – | – | ﹤0.01% | 1124 |
|
2023
Q1 | $11K | Hold |
909
| – | – | ﹤0.01% | 1097 |
|
2022
Q4 | $7K | Buy |
909
+227
| +33% | +$1.75K | ﹤0.01% | 1125 |
|
2022
Q3 | $4K | Hold |
682
| – | – | ﹤0.01% | 1171 |
|
2022
Q2 | $3K | Hold |
682
| – | – | ﹤0.01% | 1195 |
|
2022
Q1 | $6K | Hold |
682
| – | – | ﹤0.01% | 1156 |
|
2021
Q4 | $14K | Hold |
682
| – | – | ﹤0.01% | 1128 |
|
2021
Q3 | $17K | Buy |
682
+300
| +79% | +$7.48K | ﹤0.01% | 1110 |
|
2021
Q2 | $13K | Hold |
382
| – | – | ﹤0.01% | 1029 |
|
2021
Q1 | $13K | Buy |
382
+30
| +9% | +$1.02K | ﹤0.01% | 1031 |
|
2020
Q4 | $9K | Sell |
352
-512
| -59% | -$13.1K | ﹤0.01% | 1021 |
|
2020
Q3 | $9K | Hold |
864
| – | – | ﹤0.01% | 1039 |
|
2020
Q2 | $3K | Hold |
864
| – | – | ﹤0.01% | 1125 |
|
2020
Q1 | $3K | Hold |
864
| – | – | ﹤0.01% | 1129 |
|
2019
Q4 | $4K | Sell |
864
-96
| -10% | -$444 | ﹤0.01% | 1117 |
|
2019
Q3 | $5K | Hold |
960
| – | – | ﹤0.01% | 1063 |
|
2019
Q2 | $6K | Hold |
960
| – | – | ﹤0.01% | 1067 |
|
2019
Q1 | $7K | Buy |
960
+318
| +50% | +$2.32K | ﹤0.01% | 1046 |
|
2018
Q4 | $5K | Hold |
642
| – | – | ﹤0.01% | 1044 |
|
2018
Q3 | $3K | Hold |
642
| – | – | ﹤0.01% | 1093 |
|
2018
Q2 | $2K | Hold |
642
| – | – | ﹤0.01% | 1131 |
|
2018
Q1 | $1K | Buy |
+642
| New | +$1K | ﹤0.01% | 1142 |
|